EPRX•benzinga•
Eupraxia Pharmaceuticals Announces Additional Positive Clinical Data From Phase 1b/2a RESOLVE Trial Evaluating EP-104GI For Eosinophilic Esophagitis (EoE) - Press Release
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 21, 2024 by benzinga